Overstreet, A.M.
LaTorre, D.L.
Abernathy-Close, L.
Murphy, S.F.
Rhee, L.
Boger, A.M.
Adlaka, K.R.
Iverson, A.M.
Bakke, D.S.
Weber, C.R.
Boone, D.L.
This article is maintained by: Elsevier
Article Title: The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis
Journal Title: Mucosal Immunology
CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41385-018-0051-2
Content Type: article
Copyright: Copyright © 2018 © Society for Mucosal Immunology. Published by Elsevier Inc.